✦ LIBER ✦

Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial

✍ Scribed by John A Baron; Robert S Sandler; Robert S Bresalier; Angel Lanas; Dion G Morton; Robert Riddell; Erik R Iverson; David L DeMets

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular Events Associated With Ro

✍ R.S. Bresalier; R.S. Sandler; J.A. Quan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Risk of cardiovascular events and rofeco

✍ Peter Jüni; Linda Nartey; Stephan Reichenbach; Rebekka Sterchi; Paul A Dieppe; M 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 193 KB

Meta-Analysis of Adverse Cardiovascular

✍ Owais A. Khawaja; Kamran A. Shaikh; Mouaz H. Al-Mallah 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 382 KB

The association of hypertriglyceridemia

✍ M Hassan Murad; Ahmad Hazem; Fernando Coto-Yglesias; Svitlana Dzyubak; Shabnum G 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 265 KB

Meta-Analysis of Data from the Six Prima

✍ Alfred A. Bartolucci; George Howard 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Effect of rofecoxib vs. naproxen on hype

✍ Gregory P. Geba; Adam B. Polis; Norman R. Bohidar; Janet E. Rush; Thomas W. Dobb 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 35 KB